---

$3.17

+0.0050 ( +0.16% ) 270.6K

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-06-27	Sale	-12990.00	Fox Christine Ann
2024-06-27	Sale	-7416.00	Lewicki John A.
2024-06-27	Sale	-14202.00	Sermon Charles

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.